Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

TRIM29 Antikörper (AA 1-200)

Dieses Maus Monoklonal-Antikörper erkennt spezifisch TRIM29 in WB, IF und FACS. Er zeigt eine Reaktivität gegenüber Human.
Produktnummer ABIN3025034

Kurzübersicht für TRIM29 Antikörper (AA 1-200) (ABIN3025034)

Target

Alle TRIM29 Antikörper anzeigen
TRIM29 (Tripartite Motif Containing 29 (TRIM29))

Reaktivität

  • 70
  • 10
  • 9
  • 6
  • 6
  • 5
  • 4
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
Human

Wirt

  • 36
  • 33
  • 1
Maus

Klonalität

  • 37
  • 33
Monoklonal

Konjugat

  • 42
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser TRIM29 Antikörper ist unkonjugiert

Applikation

  • 44
  • 23
  • 21
  • 20
  • 14
  • 8
  • 8
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunofluorescence (IF), Flow Cytometry (FACS)

Klon

TRIM29-1042
  • Bindungsspezifität

    • 25
    • 7
    • 6
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-200

    Produktmerkmale

    It recognizes a 66 kDa protein, which is identified as Tripartite motif-containing protein 29 (TRIM29). It interacts with the intermediate filament protein vimentin, a substrate for the PKC family of protein kinases, and with hPKCI-1, an inhibitor of the PKCs. TRIM29 protein contains both zinc finger and leucine zipper motifs, suggesting that the it may form homodimers and possibly associate with DNA. High expression of TRIM29 has been reported in gastric cancer and pancreatic cancer, and correlates with enhanced tumor growth and lymph node metastasis. TRIM29 is also able to distinguish lung squamous cell carcinoma from lung adenocarcinoma with ~90 % positive accuracy, when used in a panel with TTF-1, p63, CK5/6, and Napsin-A antibodies.

    Aufreinigung

    Protein G affinity chromatography

    Immunogen

    A recombinant fragment (126 amino acid residues between aa 1-200) from the human protein was used as the immunogen for the TRIM29 antibody.

    Isotyp

    IgG2b kappa
  • Applikationshinweise

    Optimal dilution of the TRIM29 antibody should be determined by the researcher.\. Flow Cytometry: 0.5-1 μg/million cells in 0.1ml,Immunofluorescence: 0.5-1 μg/mL,Western blot: 0.5-1 μg/mL

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    0.2 mg/mL

    Buffer

    0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Store the TRIM29 antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
  • Target

    TRIM29 (Tripartite Motif Containing 29 (TRIM29))

    Andere Bezeichnung

    TRIM29

    Hintergrund

    It recognizes a 66  kDa protein, which is identified as Tripartite motif-containing protein 29 (TRIM29). It interacts with the intermediate filament protein vimentin, a substrate for the PKC family of protein kinases, and with hPKCI-1, an inhibitor of the PKCs. TRIM29 protein contains both zinc finger and leucine zipper motifs, suggesting that the it may form homodimers and possibly associate with DNA. High expression of TRIM29 has been reported in gastric cancer and pancreatic cancer, and correlates with enhanced tumor growth and lymph node metastasis. TRIM29 is also able to distinguish lung squamous cell carcinoma from lung adenocarcinoma with ~90 % positive accuracy, when used in a panel with TTF-1, p63, CK5/6, and Napsin-A antibodies.

    Pathways

    p53 Signalweg, Apoptose, DNA Reparatur, Inositol Metabolic Process, Positive Regulation of Response to DNA Damage Stimulus
Sie sind hier:
Chat with us!